Home
XENE
XENE News

Latest Xenon Pharmaceuticals Inc. (XENE) News on August 13, 2025

Xenon Announces Appointment of Darren Cline as Chief Commercial Officer

GlobeNewswire

2 months ago

Xenon Announces Appointment of Darren Cline as Chief Commercial Officer

MT Newswires

2 months ago

RBC Raises Price Target on Xenon Pharmaceuticals to $57 From $55, Keeps Outperform, Speculative Risk

Xenon Pharmaceuticals (XENE) Up 8.7% Since Last Earnings Report: Can It Continue?

Zacks

2 months ago

Xenon Pharmaceuticals (XENE) Up 8.7% Since Last Earnings Report: Can It Continue?

Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

GlobeNewswire

2 months ago

Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference

GlobeNewswire

3 months ago

Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference

Why Xenon Pharmaceuticals Inc. (XENE) Declined on Tuesday

Insider Monkey

3 months ago

Why Xenon Pharmaceuticals Inc. (XENE) Declined on Tuesday

Xenon Q1 Loss Narrower Than Expected, Pipeline Development in Focus

Zacks

3 months ago

Xenon Q1 Loss Narrower Than Expected, Pipeline Development in Focus

MT Newswires

3 months ago

RBC Adjusts Price Target on Xenon Pharmaceuticals to $55 From $58, Maintains Outperform Speculative Risk Rating

Xenon Pharmaceuticals Inc (XENE) Q1 2025 Earnings Call Highlights: Strong Financial Position ...

GuruFocus.com

3 months ago

Xenon Pharmaceuticals Inc (XENE) Q1 2025 Earnings Call Highlights: Strong Financial Position ...

MT Newswires

3 months ago

Xenon Pharmaceuticals Q1 Loss Widens; Shares Drop

Associated Press Finance

3 months ago

Xenon Pharmaceuticals: Q1 Earnings Snapshot

Xenon Reports First Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

3 months ago

Xenon Reports First Quarter 2025 Financial Results and Provides Business Update

Xenon Pharmaceuticals Inc (XENE) Q1 2025 Earnings Report Preview: What To Look For

GuruFocus.com

3 months ago

Xenon Pharmaceuticals Inc (XENE) Q1 2025 Earnings Report Preview: What To Look For

MT Newswires

3 months ago

Chardan Initiates Xenon Pharmaceuticals at Buy With $55 Price Target

Xenon to Report Q1 2025 Financial Results on May 12, 2025

GlobeNewswire

3 months ago

Xenon to Report Q1 2025 Financial Results on May 12, 2025

Wall Street Analysts See a 48.15% Upside in Xenon Pharmaceuticals (XENE): Can the Stock Really Move This High?

Zacks

3 months ago

Wall Street Analysts See a 48.15% Upside in Xenon Pharmaceuticals (XENE): Can the Stock Really Move This High?

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025

GlobeNewswire

4 months ago

Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025

Xenon to Present at Stifel 2025 Virtual CNS Forum

GlobeNewswire

5 months ago

Xenon to Present at Stifel 2025 Virtual CNS Forum

MT Newswires

6 months ago

RBC Capital Adjusts Xenon Pharmaceuticals Price Target to $58 From $56, Maintains Outperform - Speculative Risk Rating

Xenon Q4 Loss Narrower Than Expected, Pipeline Development in Focus

Zacks

6 months ago

Xenon Q4 Loss Narrower Than Expected, Pipeline Development in Focus

MT Newswires

6 months ago

Wedbush Adjusts Price Target on Xenon Pharmaceuticals to $42 From $43, Maintains Outperform Rating

MT Newswires

6 months ago

Deutsche Bank Adjusts Xenon Pharmaceuticals Price Target to $60 From $67, Maintains Buy Rating

Xenon Pharmaceuticals Inc (XENE) Q4 2024 Earnings Call Highlights: Strategic Advancements and ...

GuruFocus.com

6 months ago

Xenon Pharmaceuticals Inc (XENE) Q4 2024 Earnings Call Highlights: Strategic Advancements and ...

MT Newswires

6 months ago

Xenon Pharmaceuticals Q4 Net Loss Widens

Associated Press Finance

6 months ago

Xenon Pharmaceuticals: Q4 Earnings Snapshot

Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update

GlobeNewswire

6 months ago

Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update

What To Expect From Xenon Pharmaceuticals Inc (XENE) Q4 2024 Earnings

GuruFocus.com

6 months ago

What To Expect From Xenon Pharmaceuticals Inc (XENE) Q4 2024 Earnings

Xenon to Present at the 45th Annual TD Cowen Healthcare Conference

GlobeNewswire

6 months ago

Xenon to Present at the 45th Annual TD Cowen Healthcare Conference

Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 2025

GlobeNewswire

6 months ago

Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 2025

MT Newswires

6 months ago

Deutsche Bank Initiates Coverage on Xenon Pharmaceuticals With Buy Rating, $67 Price Target

We're Not Very Worried About Xenon Pharmaceuticals' (NASDAQ:XENE) Cash Burn Rate

Simply Wall St.

6 months ago

We're Not Very Worried About Xenon Pharmaceuticals' (NASDAQ:XENE) Cash Burn Rate

MT Newswires

7 months ago

Xenon Pharmaceuticals Insider Sold Shares Worth $2,213,997, According to a Recent SEC Filing

MT Newswires

7 months ago

Wedbush Cuts Price Target on Xenon Pharmaceuticals to $43 From $46, Keeps Outperform Rating

Xenon Outlines Key Corporate Milestone Opportunities for 2025

GlobeNewswire

7 months ago

Xenon Outlines Key Corporate Milestone Opportunities for 2025

Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue?

Zacks

8 months ago

Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue?

Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024

GlobeNewswire

8 months ago

Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024

Xenon to Showcase New Long-Term Azetukalner Data at AES 2024

GlobeNewswire

9 months ago

Xenon to Showcase New Long-Term Azetukalner Data at AES 2024

JPMorgan Selects These 2 Stocks as Must-Haves for 2025

TipRanks

9 months ago

JPMorgan Selects These 2 Stocks as Must-Haves for 2025

Xenon to Present at Upcoming Investor Conferences

GlobeNewswire

9 months ago

Xenon to Present at Upcoming Investor Conferences

Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus

Zacks

9 months ago

Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus

Xenon Pharmaceuticals Inc (XENE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...

GuruFocus.com

9 months ago

Xenon Pharmaceuticals Inc (XENE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...

MT Newswires

9 months ago

Xenon Pharmaceuticals Q3 Net Loss Widens

Associated Press Finance

9 months ago

Xenon Pharmaceuticals: Q3 Earnings Snapshot

Xenon Reports Q3 2024 Financial Results and Business Update

GlobeNewswire

9 months ago

Xenon Reports Q3 2024 Financial Results and Business Update

Earnings To Watch: Xenon Pharmaceuticals Inc (XENE) Reports Q3 2024 Result

GuruFocus.com

9 months ago

Earnings To Watch: Xenon Pharmaceuticals Inc (XENE) Reports Q3 2024 Result

Xenon to Report Q3 2024 Financial Results on November 12, 2024

GlobeNewswire

9 months ago

Xenon to Report Q3 2024 Financial Results on November 12, 2024

Longboard Set to be Acquired by Lundbeck for $2.6B, Stock Soars 52%

Zacks

10 months ago

Longboard Set to be Acquired by Lundbeck for $2.6B, Stock Soars 52%

Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe

Zacks

10 months ago

Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe

Xenon Pharmaceuticals Inc (XENE) Q2 2024 Earnings Call Highlights: Strategic Advances and ...

GuruFocus.com

10 months ago

Xenon Pharmaceuticals Inc (XENE) Q2 2024 Earnings Call Highlights: Strategic Advances and ...

Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference

GlobeNewswire

10 months ago

Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference

MT Newswires

10 months ago

HC Wainwright Initiates Coverage on Xenon Pharmaceuticals With Buy Rating, $53 Price Target

Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress

GlobeNewswire

a year ago

Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress

Xenon Pharmaceuticals Inc. (XENE): Among the Best Mid-Cap Healthcare Stocks To Buy Now

Insider Monkey

a year ago

Xenon Pharmaceuticals Inc. (XENE): Among the Best Mid-Cap Healthcare Stocks To Buy Now

We're Hopeful That Xenon Pharmaceuticals (NASDAQ:XENE) Will Use Its Cash Wisely

Simply Wall St.

a year ago

We're Hopeful That Xenon Pharmaceuticals (NASDAQ:XENE) Will Use Its Cash Wisely

Xenon (XENE) Focuses on Neuro Candidate Amid Pipeline Woe

Zacks

a year ago

Xenon (XENE) Focuses on Neuro Candidate Amid Pipeline Woe

MT Newswires

a year ago

Xenon Pharmaceuticals Names Matthew Ronsheim Chief Operating Officer

Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer

GlobeNewswire

a year ago

Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer

Xenon (XENE) Q2 Earnings Miss, Pipeline in Focus, Stock Down

Zacks

a year ago

Xenon (XENE) Q2 Earnings Miss, Pipeline in Focus, Stock Down

MT Newswires

a year ago

Wedbush Adjusts Xenon Pharmaceuticals' PT to $49 From $50, Keeps Outperform Rating

MT Newswires

a year ago

Xenon Pharmaceuticals Q2 Net Loss Widens

Associated Press Finance

a year ago

Xenon Pharmaceuticals: Q2 Earnings Snapshot

Xenon Reports Q2 2024 Financial Results and Business Update

GlobeNewswire

a year ago

Xenon Reports Q2 2024 Financial Results and Business Update

Xenon to Report Q2 2024 Financial Results on August 8, 2024

GlobeNewswire

a year ago

Xenon to Report Q2 2024 Financial Results on August 8, 2024

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Could Be 24% Below Their Intrinsic Value Estimate

Simply Wall St.

a year ago

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Could Be 24% Below Their Intrinsic Value Estimate

Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag

Zacks

a year ago

Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag

Is Xenon Pharmaceuticals Inc. (XENE) One of the Best Healthcare Stocks Under $50?

Insider Monkey

a year ago

Is Xenon Pharmaceuticals Inc. (XENE) One of the Best Healthcare Stocks Under $50?

Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire

a year ago

Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Shareholders Will Probably Not Have Any Issues With Xenon Pharmaceuticals Inc.'s (NASDAQ:XENE) CEO Compensation

Simply Wall St.

a year ago

Shareholders Will Probably Not Have Any Issues With Xenon Pharmaceuticals Inc.'s (NASDAQ:XENE) CEO Compensation

Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting

GlobeNewswire

a year ago

Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting

Hedge Funds are Racking Up Shares of This Healthcare Stock

Insider Monkey

a year ago

Hedge Funds are Racking Up Shares of This Healthcare Stock

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2024 Earnings Call Transcript

GuruFocus.com

a year ago

Xenon Pharmaceuticals Inc (XENE) Reports Increased Losses in Q1 2024, Despite Advancements in ...

Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus

Zacks

a year ago

Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus

MT Newswires

a year ago

Wedbush Trims Xenon Pharmaceuticals' Price Target to $50 From $51, Maintains Outperform Rating

MT Newswires

a year ago

Xenon Pharmaceuticals Q1 Net Loss Narrows

Associated Press Finance

a year ago

Xenon Pharmaceuticals: Q1 Earnings Snapshot

Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update

Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024

GlobeNewswire

a year ago

Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024

Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference

GlobeNewswire

a year ago

Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference

What Makes Xenon Pharmaceuticals (XENE) a New Buy Stock

Zacks

a year ago

What Makes Xenon Pharmaceuticals (XENE) a New Buy Stock

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update

GlobeNewswire

a year ago

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update

Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting

GlobeNewswire

a year ago

Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting

Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

GlobeNewswire

a year ago

Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire

a year ago

Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

Xenon Pharmaceuticals (NASDAQ:XENE) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

a year ago

Xenon Pharmaceuticals (NASDAQ:XENE) Is In A Good Position To Deliver On Growth Plans

Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days

GlobeNewswire

a year ago

Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days

Insider Sell: EVP, Strategy & Innovation Sherrington Robin Sells 7,137 Shares of Xenon ...

GuruFocus.com

a year ago

Insider Sell: EVP, Strategy & Innovation Sherrington Robin Sells 7,137 Shares of Xenon ...

Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024

GlobeNewswire

a year ago

Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcript

Xenon (XENE) Q4 Earnings Top Estimates, Pipeline in Focus

Zacks

a year ago

Xenon (XENE) Q4 Earnings Top Estimates, Pipeline in Focus

GuruFocus.com

a year ago

Xenon Pharmaceuticals Inc (XENE) Reports Full Year and Q4 2023 Financial Results

Associated Press Finance

a year ago

Xenon Pharmaceuticals: Q4 Earnings Snapshot

Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

GlobeNewswire

a year ago

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition

InvestorPlace

a year ago

3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition

Is Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Trading At A 39% Discount?

Simply Wall St.

2 years ago

Is Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Trading At A 39% Discount?

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Columbia Sportswear Co Earnings Call

Share on Social Networks: